ABBEY DONZE: Open Payments
NPI 1578296299 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,893 in 208 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $710 · 2025 $4,893
Food & beverage: $4,817Education: $76
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $623 |
| Novartis Pharmaceuticals Corporation | 19 | $424 |
| Genentech USA, Inc. | 18 | $395 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $322 |
| CSL Behring | 11 | $309 |
| GENZYME CORPORATION | 11 | $297 |
| Regeneron Healthcare Solutions, Inc. | 11 | $297 |
| Amgen Inc. | 16 | $266 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $258 |
| Organon LLC | 9 | $253 |
Products named: TEZSPIRE, DUPIXENT, Xolair, AYVAKIT, NEFFY, NUCALA, VTAMA, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
